Skip to content
Clinical Trial Events
SCOPE Europe 2026

Talk Risk-Based Quality Management track

From Signals to Decisions: Making RBQM Actionable at the Study-Level

Wed, Oct 14, 2026 · 9:10–9:35 AM CEST InterContinental Barcelona

About this session

Risk-Based Quality Management generates increasing volumes of study-level signals, yet translating those signals into timely, consistent decisions remains a challenge. In the context of ICH E6(R3), this session examines why decisions stall and how to operationalise decision-making in practice. Practical approaches to defining thresholds, clarifying ownership, and enabling timely, traceable actions will support more effective, inspection-ready study oversight and continuous improvement.

Speaker

  • Lydia Matombo

    TA Director, Oncology, Risk-Based Quality Management · AbbVie

    Speaker

Reviews of this session

No reviews yet

Were you in the room? Reviews are open until Oct 14, 2027.

Write the first review